fda banning tirzepatide approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly Eli Lilly's tirzepatide is off

Despite the reduction in EE and a relative shift in substrate oxidation, both of which indicate a negative energy balance, it is of interest to observe that liraglutide treatment at doses of 1.8 mg and above continues to promote satiety and reduce hunger

Studies have shown that new weight loss drugs such as Ozempic and Wegovy can reduce body weight by 10% to 20%

There were also concerns about rare cases of pancreatitis (still more frequent in patients with diabetes) and thyroid cancer (there is a black box warning)

& Foltin, R

While an overdose of APAP yields peak serum concentrations (10 20 g/mL) within 4 hours, a patient taking the medication safely will achieve peak concentrations within 1.5 hours, with a half-life of 1.5 3 hours

But as a registered dietitian who specializes in GLP-1 nutrition, I've found that one of the biggest misconceptions is that having little to no appetite is always a good thing